
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
This activity focuses entirely on issues related to the Organs at Risk (OAR) in the setting of thoracic radiation. Discussion centers on protecting the OARs and managing acute and late toxicities. Each speaker focuses on a different clinical situation. The clinical situations being presented are 1) conventionally fractionated lung treatment, 2) stereotactic body radiation therapy (SBRT) of peripheral lung lesions, and 3) SBRT for central/ultra-central lung lesions. Each speaker discusses dose constraints, planning techniques and technical solutions (e.g., gating, breath hold, tumor tracking etc.) to help decrease the dose to all critical OARs. Each speaker also discusses management of acute and late toxicity related to the treatment of lung cancer.
Topics:
- Lung OAR: Conventional Fractionated Treatment
Julianna K. Bronk, MD, PhD - Lung/Thoracic OAR: Central and Ultracentral SBRT
Matthew S. Ning, MD, MPH - Peripheral Lung SBRT
Shane Mesko, MD, MBA - Q and A
Christopher Hays Pope - Moderator
Full Panel
This activity is available from April 8, 2025, through 11:59 p.m. Eastern time on April 7, 2027.
The content was originally presented and recorded at the 2024 ASTRO Annual Meeting.
Target Audience
The activity is designed to meet the interests of radiation oncologists, radiation dosimetrists and residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Determine the appropriate dose constraints to be utilized in common clinical situations including SBRT to central and peripheral lung lesions.
- Assess common side effects of lung treatment and determine appropriate management.
- Christopher Hays Pope, MD, is employed by CARTI.
- Julianna K. Bronk, MD, PhD, is employed by The University of Texas MD Anderson Cancer Center.
- Matthew S. Ning, MD, MPH, is employed by The University of Texas MD Anderson Cancer Center.
- Shane Mesko, MD, MBA, is employed by University of California, Irvine/Scripps Cancer Center. Dr. Mesko receives compensation/payment from Oscar Health.
The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
- Nonmember: $149
- Member: $99
- Member-in-Training: $49
- Student/Graduate Student/PGY-1 Member: $49
- Postdoctoral Fellow Member: $49
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until April 7, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.